Dark Forest Capital Management LP Alx Oncology Holdings Inc Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$5.89 - $19.46 $3,056 - $10,099
519 Added 63.92%
1,331 $11,000
Q1 2022

May 13, 2022
SELL
$13.65 - $22.06 $244,881 - $395,756
-17,940 Reduced 95.67%
812 $13,000
Q4 2021

Feb 11, 2022
BUY
$21.49 - $74.4 $402,980 - $1.4 Million
18,752 New
18,752 $403,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $68.9M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email